Most people know GLP-1 medications as weight loss drugs. But Zepbound (tirzepatide) received a second FDA approval for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity — and this changes the insurance picture dramatically.
Why the OSA Indication Matters for Pricing
Medicare Part D is prohibited from covering weight loss drugs. But it CAN cover Zepbound when prescribed for sleep apnea. This means Medicare patients with OSA can access Zepbound through standard Part D coverage right now — without waiting for the July 2026 Bridge program.
The same principle applies to many commercial insurance plans that exclude weight loss drugs but cover medications for other FDA-approved indications.
Every Pricing Pathway for Sleep Apnea Patients
| Pathway | Monthly Cost | Requirements |
|---|---|---|
| Medicare Part D (OSA indication) | Varies by plan | OSA diagnosis + BMI ≥27 + Part D enrollment |
| Medicare Part D (with $2,100 cap) | ≤$175/mo avg | Annual out-of-pocket capped at $2,100 |
| Medicare GLP-1 Bridge (July 2026) | $50/mo | BMI ≥35 or BMI ≥27 with conditions |
| Commercial insurance + savings card | $25/mo | Plan covers Zepbound for OSA |
| LillyDirect vials (self-pay) | $299–449/mo | Valid prescription, no insurance needed |
| Compounded tirzepatide | $179–299/mo | No OSA diagnosis needed |
Do You Qualify?
To access Zepbound through the OSA pathway, you need:
- Confirmed OSA diagnosis — from a sleep study (polysomnography) or home sleep apnea test
- Moderate-to-severe OSA — typically defined as an Apnea-Hypopnea Index (AHI) of 15 or higher
- BMI of 27 or higher
- Prescription from a licensed provider specifying Zepbound for OSA (not weight loss)
Cash-Pay Alternatives
If insurance doesn't cover you through the OSA pathway, these providers offer compounded tirzepatide without requiring a sleep apnea diagnosis:
| Provider | Starting Price | Details |
|---|---|---|
| Yucca Health | $149/mo | Check Price → Paid link |
| Novi | $174/mo | Check Price → Paid link |
| Synergy Rx | $199/mo | Check Price → Paid link |
| Sprout Health | $229/mo | Check Price → Paid link |
Key Takeaways
- Zepbound is the only GLP-1 FDA-approved for sleep apnea
- Medicare Part D can cover Zepbound for OSA right now — no Bridge needed
- Commercial insurance + savings card: as low as $25/month
- 80% of moderate-to-severe OSA is undiagnosed — a sleep study could unlock coverage
- Cash-pay compounded tirzepatide from $179/month if insurance isn't an option
Compare All GLP-1 Prices
See today's lowest verified prices from vetted telehealth providers.
Compare Prices →